10X Genomics Inc (TXG) Stock Analysis
Verdict: WATCH (do not buy)
Post-earnings momentum has pushed valuation to an unsustainable 11.8x P/S while insiders liquidate and price nears a -27% analyst gap.
Investment score: 42/100
Analysis as of
Is 10X Genomics Inc stock worth reviewing? AI model thesis
The model score of 42/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 65/100 (weight 15%)
- Earnings Quality: 80/100 (weight 15%)
- Insider Sentiment: 10/100 (weight 10%)
- Analyst Consensus: 35/100 (weight 10%)
- Risk-Adjusted Return: 30/100 (weight 15%)
10X Genomics Inc opportunities and risks
What speaks for TXG
- Sequential Earnings Outperformance
What speaks against TXG
- Valuation Overextension (P/S 11.8x)
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| TXG | n/a | 11.9x | 246.7x | 70.0% | -12.2% | 1.7% |
| TEM | n/a | 6.7x | n/a | 64.0% | -17.8% | -2.9% |
| BIO | 43.5x | 3.8x | 19.5x | 51.9% | 8.6% | 3.6% |
| AVTR | n/a | 1.4x | 102.3x | 31.8% | -8.8% | 4.8% |
| RGEN | 223.9x | 11.9x | 77.4x | 51.1% | 5.3% | 1.2% |
| BRKR | n/a | 2.6x | 43.4x | 46.7% | -2.0% | 1.0% |
| Peer median | n/a | 3.8x | 43.4x | 51.1% | -2.0% | 1.2% |
Frequently asked questions about 10X Genomics Inc (TXG)
Is TXG stock a good investment?
The cached TradeMates AI model rates 10X Genomics Inc as WATCH (do not buy) with an investment score of 42/100. The model score of 42/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is TXG stock a buy?
The TradeMates model verdict for TXG is WATCH (do not buy) with an investment score of 42/100. Treat this as a model signal to review, not a personal buy recommendation.